NCT06808945

Brief Summary

The objective of this study is to determine the feasibility and effectiveness of a home-based multimodal prehabilitation program in patients anticipated to be waitlisted for LT. Patients will participate in an eight week prehabilitation program consisting of physical exercise, nutritional support, smoking cessation and psychological counselling.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Oct 2024Jul 2026

Study Start

First participant enrolled

October 2, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 25, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

February 5, 2025

Status Verified

February 1, 2025

Enrollment Period

1.5 years

First QC Date

November 25, 2024

Last Update Submit

February 4, 2025

Conditions

Keywords

prehabilitationliver transplant

Outcome Measures

Primary Outcomes (3)

  • Program satisfaction

    Self-designed questionnaire score (score between 1-10, higher score means higher satisfaction)

    At completion of the prehabilitation program (8 weeks after baseline/screening for LT)

  • Program compliance

    Number of sessions that patient participates in the fitness training, the counselling on nutrition, smoking cessation and psychosocial sessions will be registered.

    At completion of the prehabilitation program (8 weeks after baseline/screening for LT)

  • Percentage of patients willing to participate in the prehabilitation program

    It will be registered which patients are willing and not willing to participate

    At the outpatient clinic, when patients make their appointment for screening for LT

Secondary Outcomes (11)

  • Aerobic capacity

    At start of the program, when patients are admitted for screening, they will perform a CPET as baseline. After eight weeks of home-based training the CPET will be reassessed.

  • Sarcopenia

    At baseline (before start prehabilitation program) and after eight weeks.

  • Anthropometry

    At baseline (before start prehabilitation program) and after eight weeks.

  • Functional capacity

    At baseline (before start prehabilitation program) and after eight weeks.

  • Functional mobility

    At baseline (before start prehabilitation program) and after eight weeks.

  • +6 more secondary outcomes

Study Arms (1)

Home based prehabilitation

EXPERIMENTAL

Participants will be subjected to a training period of eight weeks of a home-based multimodal prehabilitation program. The program consists of an exercise program, nutritional support, smoking cessation and psychological counselling.

Other: Prehabilitation program

Interventions

Participants will be subjected to an eight week home-based multimodal prehabilitaiton program. The program consists of an exercise program, nutritional support, smoking cessation and psychological counselling.

Home based prehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years,
  • Anticipated waitlisting for LT,
  • Speaks the Dutch language,
  • Understands the purpose of the study and has given written informed consent.

You may not qualify if:

  • Experienced a major adverse cardiovascular event in the past six months,
  • Experienced a cerebrovascular incident in the past six months,
  • Medical history of an uncontrolled heart rhythm disorder,
  • Hepatic encephalopathy grade 3 or 4,
  • Acute liver failure,
  • Acute-on-chronic liver failure,
  • Hospitalization at start of the study.
  • Non-treated esophageal varices (i.e., no previous variceal eradication endoscopy or adequately dosed NSBB)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus Medical Center

Rotterdam, 3015 CN, Netherlands

RECRUITING

MeSH Terms

Conditions

Sedentary Behavior

Condition Hierarchy (Ancestors)

Behavior

Central Study Contacts

Lysanne P.M. Beuk

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 25, 2024

First Posted

February 5, 2025

Study Start

October 2, 2024

Primary Completion

April 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

February 5, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations